Facebook X-twitter Youtube Linkedin

Press Releases

Stay informed with the latest announcements, scientific updates, and company milestones from PridCor Therapeutics.
January 6, 2026

PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVID Program

TUSCALOOSA, Ala., Jan. 06, 2026 (GLOBE NEWSWIRE) — PridCor Therapeutics, a clinical-stage biopharmaceutical company developing antiviral therapies for infection-associated chronic illnesses...

Read More
September 23, 2025

PridCor Therapeutics Principal Investigator Dr. David Putrino Participates in National Long COVID Roundtable Convened by Secretary Robert F. Kennedy Jr.

TUSCALOOSA, Ala., Sept. 23, 2025 (GLOBE NEWSWIRE) — PridCor Therapeutics today announced that Dr. David Putrino, principal investigator of the...

Read More
September 4, 2025

PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen

September 04, 2025 10:32 ET | Source: GlobalNewsWire-New Preprint: PridCor Therapeutics LLC has released a pre-print detailing a case series...

Read More
Facebook X-twitter Youtube Linkedin